PT-141 10 mg OxyPharma, available for order in Ukraine. PT-141 is a comparatively new peptide that has built a loyal following thanks to a track record people actually trust. It was developed to raise libido and potency. The Indian OxyPharma version is a synthetic aphrodisiac with a sensible safety profile, used around the world for sexual dysfunction in both sexes. The key advantage: it works on the body without putting pressure on the cardiovascular system. The target is the central nervous system — more precisely, the hypothalamus — where it raises sexual desire at the source. A fair number of men and women have taken part in trials of the drug. Across the board they described feeling more confident, younger, charged with unspent energy, and reporting strong arousal. For many, effects began about two hours after administration, with the peak around the four-hour mark. Bremelanotide is a synthetic peptide, so it works directly on the neural pathways tied to sexual desire. That sets it apart from PDE5 inhibitors, which act on vascular receptors instead. PT-141 does not merely enhance potency — it initiates it. People running the drug have also noted a broader lift in mood: more relaxed, higher self-esteem, improved intimacy with partners. Storage conditions for PT-141 OxyPharma. The ideal storage temperature is two to eight degrees. Store the compound dry whenever possible, and keep the reconstituted solution in a cool place. Method of use. Administration is subcutaneous only. Dosages vary: Trial — 0.30 mg (an opening dose used to gauge how the active components feel on the body, after which the dose is nudged upwards to match body weight). Average — 0.70 mg. Optimal — 1 mg. Strong — 1.5 mg. One vial of PT-141 contains 10 mg of active peptide. Reconstitution is straightforward. For a single vial, add 2 ml of sterile water for injection. At that dilution the daily dose by body weight works out to: 100 kg — 1 mg per day (the “20” mark on an insulin syringe); 75 kg — 0.75 mg per day (mark “15”); 50 kg — 0.5 mg per day (mark “10”). After the injection the face may flush slightly for about 30 minutes. That reaction is normal. Fair enough — the body is simply responding to PT-141. This store sources the peptide directly, and prices sit close to cost. Everything on the shelf has been marked down, so the original PT-141 typically comes in cheaper here than at similar outlets. Peptides, PT-141 (10 mg) OxyPharma.
Peptide PT-141 (10mg) OxyPharma
€0.00
PT-141 10 mg OxyPharma — product overview
PT-141 is a relatively recent peptide product that has built a reputation for genuine effectiveness and gathered a solid user base along the way. The compound was developed to raise libido and improve potency. Indian-produced PT-141 is a synthetic aphrodisiac with a decent safety profile. It is used globally for the management of sexual dysfunction across both sexes. One notable feature: the drug has a positive effect on the body without acting through the cardiovascular system. The mechanism involves the central nervous system — specifically the hypothalamus — where it raises sexual desire.
Many men and women have taken part in trials of the compound. Consistently, participants reported feeling more self-assured and younger, with greater energy and a markedly stronger arousal response. The effect typically becomes evident within two hours after dosing. Peak activity arrives at around four hours.
Bremelanotide is a synthetic peptide, so it acts directly on the neural pathways that handle sexual desire. That sets it apart from PDE5 inhibitors, which work on vascular receptors. PT-141 doesn’t just support potency — it drives it.
People taking the drug have reported a general lift in condition: more relaxed, with higher self-esteem and a better sexual connection with their partner.
Storage conditions for PT-141 OxyPharma
Optimal storage temperature sits between two and eight degrees. The compound should be kept in dry form. The reconstituted solution is best stored in a cool place.
Method of use — PT-141
Administration is subcutaneous only. Dosing varies:
Trial — 0.30 mg (starting dose, used to gauge the effect of the active components; subsequently adjusted by body weight).
Average — 0.70 mg.
Optimal — 1 mg.
Strong — 1.5 mg.
Each vial of PT-141 contains 10 mg of active peptide. Preparing the injection solution is straightforward — one vial takes 2 ml of water for injection (sterile, essential). At this dilution the daily dose maps out as follows:
body weight 100 kg — 1 mg per day (mark “20” on an insulin syringe);
body weight 75 kg — 0.75 mg per day (mark “15” on an insulin syringe);
body weight 50 kg — 0.5 mg per day (mark “10” on an insulin syringe).
After the injection, slight facial redness may appear for about 30 minutes. This is a normal reaction to PT-141. Peptides, PT-141 (10 mg) OxyPharma
Out of stock
PT-141 (Bremelanotide) is a melanocortin receptor agonist, acting centrally on sexual arousal pathways rather than vascular tissue — a different route to the same destination compared with PDE5 inhibitors. Dosing lands at 0.5–2 mg sub-cut, taken 45 to 60 minutes before desired effect. The 10 mg vial reconstitutes with 2 ml bacteriostatic water, giving twenty 1 mg doses. Flushing, mild nausea and short-term skin darkening are the most common on-dose effects. Refrigerate the reconstituted vial and use within four weeks.
| Peptide | PT-141 (Bremelanotide) |
| Vial content | 10 mg lyophilised |
| Manufacturer | OxyPharma |
| Receptor target | Melanocortin receptor agonist |
| Form | Freeze-dried vial for sub-cut injection |
| Typical dose | 0.5–2 mg per use |
| Reconstitution | Bacteriostatic water, 2 ml |
| Storage after reconstitution | 2–8 °C, used within 30 days |
PT-141, also called Bremelanotide, is a melanocortin-receptor agonist derived from Melanotan 2 but reworked for a different purpose. 10 mg vial, sub-cut after reconstitution.
Users dose 0.5–2 mg sub-cut around 30–60 minutes before activity. It acts centrally — in the hypothalamus — to drive sexual arousal, bypassing vascular pathways entirely. Flushing and nausea at higher doses are the typical trade-offs. Suited to adults seeking a non-PDE5 option.
Frequently Asked Questions
How does PT-141 affect libido in both sexes?
PT-141, or Bremelanotide, is a melanocortin receptor agonist used for libido in both men and women. Typical sub-cutaneous doses sit at 0.5–2 mg.
How quickly does PT-141 start to work?
PT-141 is a melanocortin agonist. It acts on the central nervous system and is best known for restoring libido in both men and women.
How long does the effect of PT-141 last?
The usual dosing is 0.5 to 2 mg subcutaneous as needed, kept up for on-demand use.
Does PT-141 need to be cycled off periodically?
Cycling is the preferred approach: a few weeks on, then a break of similar length.
How quickly does PT-141 start to work?
Most users notice effects within 2–6 hours of a sub-cutaneous injection of 0.5–2 mg.
Reviews
There are no reviews yet